Publication | Open Access

Results of a phase I study in patients suffering from secondary-progressive multiple sclerosis demonstrating the safety of the amino acid copolymer PI-2301 and a possible induction of an anti-inflammatory cytokine response☆

InflammationPossible InductionAutoimmune DiseaseDisease ProgressionSecondary-progressive Multiple SclerosisImmunologyImmune RegulationAutoimmunityNeurologyMultiple SclerosisAnti-inflammatory Cytokine Response☆MedicineNeuroinflammation